Evotec SE (EVO) Invested Capital (2009 - 2026)
Evotec SE's (EVO) quarterly Invested Capital came in at $1.3 billion in Q2 2026, down 10.38% year-over-year from $1.5 billion in Q2 2025, and up 4.25% quarter-over-quarter from $1.3 billion in Q1 2026.
Analysis
Evotec SE (EVO) Invested Capital (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Invested Capital across 9 years of filings, most recently posting $1.3 billion for Q2 2026.
- In Q2 2026, Invested Capital fell 10.38% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $1.3 billion (down 10.38% YoY), while the FY2025 annual figure was $1.4 billion, down 5.61% from the prior year.
- Invested Capital came in at $1.3 billion for Q2 2026 at Evotec SE, up from $1.3 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $1.9 billion in Q4 2023 to a low of $1.3 billion in Q1 2026.
- Average Invested Capital over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2025.
- Year-over-year, Invested Capital climbed 8.26% in 2023 and declined 20.59% in 2024.
- Over 5 years, Invested Capital stood at $1.7 billion in 2022, then gained by 8.26% to $1.9 billion in 2023, then decreased by 20.59% to $1.5 billion in 2024, then retreated by 1.49% to $1.5 billion in 2025, then dropped by 9.71% to $1.3 billion in 2026.
- Per Business Quant data, the three most recent Invested Capital figures were $1.3 billion in Q2 2026, $1.3 billion in Q1 2026, and $1.5 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 22.30 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 12.77 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 5.47 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.58 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.33 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Bn |
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.47 Bn |
| Sep 30, 2025 | 1.50 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 1.49 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Jun 30, 2023 | 1.86 Bn |
| Dec 31, 2022 | 1.74 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Mar 31, 2022 | 1.85 Bn |
| Dec 31, 2021 | 1.99 Bn |
| Sep 30, 2021 | 1.55 Bn |
| Dec 31, 2020 | 1.28 Bn |
| Sep 30, 2010 | 175.49 Mn |
| Jun 30, 2010 | 156.11 Mn |
| Mar 31, 2010 | 1.32 Mn |
| Dec 31, 2009 | 170.52 Mn |